Dr. Daniela Salvemini's lab focuses on understanding how chemotherapy can impair cognition, a condition known as chemotherapy-induced cognitive impairment (chemobrain). The research investigates how molecules in the brain, particularly sphingosine-1-phosphate receptors, contribute to cognitive decline after chemotherapy. The goal is to find potential treatments that could lessen this side effect for cancer survivors.